WELL · Insider Trading
Welltower Inc.
Every open-market purchase and sale reported by WELL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-30 | Timothy McHugh | Co-President and CFO | A | +11 | +$1.91K |
| 2026-08-27 | Andrew Gundlach | Director | Buy | +10,000 | +$2.41M |
| 2026-08-24 | Dennis G Lopez | Director | A | +73 | +$17.33K |
| 2026-06-29 | Shankh Mitra | CEO | MIXED | −3,835 | +$2.95K |
| 2026-05-27 | Shankh Mitra | CEO | G | −162 | — |
| 2026-05-26 | Dennis G Lopez | Director | A | +63 | +$13.61K |
| 2026-05-05 | Kenneth J Bacon | Director | C | +2,627 | — |
| 2026-05-01 | Shankh Mitra | CEO | G | −700 | — |
| 2026-02-27 | Kenneth J Bacon | Director | A | +2,112 deriv. | — |
| 2026-02-27 | Karen B DeSalvo | Director | A | +1,056 | — |
| 2026-02-27 | Dennis G Lopez | Director | A | +1,787 | — |
| 2026-02-27 | Ade J. Patton | Director | A | +2,112 deriv. | — |
| 2026-02-27 | Sergio Rivera | Director | A | +1,056 | — |
| 2026-02-27 | Johnese Spisso | Director | A | +1,056 | — |
| 2026-02-27 | Andrew Gundlach | Director | A | +3,574 deriv. | — |
| 2026-02-27 | Kathryn M Sullivan | Director | A | +2,112 deriv. | — |
| 2026-02-18 | Joshua Fieweger | SVP, Chief Accounting Officer | A | +39,856 deriv. | — |
| 2026-02-18 | Matthew Grant Mcqueen | Chief Legal Officer | G | −541 | — |
| 2026-02-18 | John F. Burkart | Vice Chairman and COO | A | +391,692 deriv. | — |
| 2026-02-18 | Nikhil Chaudhri | Co-President and CIO | A | +215,576 deriv. | — |
| 2026-02-18 | Timothy McHugh | Co-President and CFO | A | +413,192 deriv. | — |
| 2026-02-18 | Shankh Mitra | CEO | A | +940,540 deriv. | — |
| 2026-01-20 | Joshua Fieweger | SVP, Chief Accounting Officer | F | −124 | −$23.33K |
| 2026-01-05 | Andrew Gundlach | Director | A | +98 deriv. | — |
| 2026-01-05 | Dennis G Lopez | Director | A | +57 | — |
| 2025-12-16 | Timothy McHugh | Co-President and CFO | G | −500 | — |
| 2025-12-02 | Shankh Mitra | CEO | A | +64 | +$8.44K |
| 2025-12-02 | Nikhil Chaudhri | Co-President and CIO | A | +31 | +$4.09K |
| 2025-12-02 | John F. Burkart | Vice Chairman and COO | A | +39 | +$5.15K |
| 2025-12-02 | Timothy McHugh | Co-President and CFO | A | +53 | +$6.99K |
| 2025-12-02 | Joshua Fieweger | SVP, Chief Accounting Officer | A | +71 | +$7.13K |
| 2025-12-02 | Matthew Grant Mcqueen | Chief Legal Officer | A | +71 | +$9.37K |
| 2025-11-21 | Dennis G Lopez | Director | A | +62 | +$12.25K |
| 2025-10-31 | Shankh Mitra | CEO | A | +4,970,292 deriv. | — |
| 2025-10-31 | Nikhil Chaudhri | Co-President and CIO | A | +150 | +$17.09K |
| 2025-10-31 | Timothy McHugh | Co-President and CFO | A | +61 | +$6.95K |
| 2025-10-31 | John F. Burkart | Vice Chairman and COO | A | +141 | +$16.06K |
| 2025-10-31 | Matthew Grant Mcqueen | Chief Legal Officer | A | +81 | +$9.23K |
| 2025-08-25 | Dennis G Lopez | Director | A | +73 | +$12.19K |
| 2025-07-02 | Andrew Gundlach | Director | Buy | +20,000 | +$3.03M |
| 2025-06-17 | Shankh Mitra | CEO | MIXED | −383 | +$12.76K |
| 2025-06-11 | Shankh Mitra | CEO | Sell | −62,204 deriv. | — |
| 2025-06-10 | Shankh Mitra | CEO | Sell | −24,013 deriv. | — |
| 2025-06-10 | Timothy McHugh | Co-President and CFO | Sell | −13,116 deriv. | — |
| 2025-06-10 | John F. Burkart | Vice Chairman and COO | Sell | −8,853 deriv. | — |
| 2025-06-10 | Matthew Grant Mcqueen | Chief Legal Officer | Sell | −8,853 deriv. | — |
| 2025-06-10 | Nikhil Chaudhri | Co-President and CIO | Sell | −13,116 deriv. | — |
| 2025-05-23 | Dennis G Lopez | Director | A | +108 | +$15.87K |
| 2025-05-01 | Karen B DeSalvo | Director | Sell | −4,000 | −$605.72K |
| 2025-03-10 | Karen B DeSalvo | Director | A | +1,434 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Shankh Mitra | CEO | 76,556 | $18.17M |
| Matthew Grant Mcqueen | Chief Legal Officer | 26,881 | $6.38M |
| Sergio Rivera | Director | 26,611 | $6.32M |
| Andrew Gundlach | Director | 25,000 | $5.93M |
| Timothy McHugh | Co-President and CFO | 23,435 | $5.56M |
| Joshua Fieweger | SVP, Chief Accounting Officer | 21,269 | $5.05M |
| Dennis G Lopez | Director | 18,597 | $4.41M |
| Johnese Spisso | Director | 16,057 | $3.81M |
| Kenneth J Bacon | Director | 14,306 | $3.40M |
| Karen B DeSalvo | Director | 12,369 | $2.94M |
| Ade J. Patton | Director | 8,241 | $1.96M |
| Kathryn M Sullivan | Director | 6,598 | $1.57M |
| John F. Burkart | Vice Chairman and COO | 1,644 | $390.15K |
| Nikhil Chaudhri | Co-President and CIO | 449 | $106.56K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the WELL quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.